Elon Musk’s brain chip startup Neuralink raises its capitalization to $5 billion. In this respect informs Reuters cites the results of a round of private trading in the company’s stock.
A year ago, Neuralink was valued at $2 billion by investors. The startup managed to raise more money after gaining approval from the US Food and Drug Administration (FDA) to test implants in humans.
Neuralink has offered its shares at $55 in a private auction, but journalists do not know whether the deals were made under these conditions, Reuters reported. At the same time, the publication writes that although, according to experts, Neuralink will be able to commercialize its technologies no earlier than in 10 years, investors reacted to the auction with great enthusiasm.
Reuters writes that within the framework of private trade, investors are mostly Neuralink employees and the company’s leading partners. Such transactions are irrelevant and do not reflect the true value of the company.
Formerly socialbites.ca Wrote It’s about Elon Musk’s mother being the cover hero of the Greek fashion magazine Instyle.